Authors:
van Tilburg, EW
van der Klein, PAM
de Groote, M
Beukers, MW
Ijzerman, AP
Citation: Ew. Van Tilburg et al., Substituted 4-phenyl-2-(phenylcarboxamido)-1,3-thiazole derivatives as antagonists for the adenosine A(1) receptor, BIOORG MED, 11(15), 2001, pp. 2017-2019
Authors:
van Muijlwijk-Koezen, JE
Timmerman, H
Vollinga, RC
Kunzel, JFV
de Groote, M
Visser, S
Ijzerman, AP
Citation: Je. Van Muijlwijk-koezen et al., Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists, J MED CHEM, 44(5), 2001, pp. 749-762
Authors:
Schrier, SM
van Tilburg, EW
van der Meulen, H
Ijzerman, AP
Mulder, GJ
Nagelkerke, JF
Citation: Sm. Schrier et al., Extracellular adenosine-induced apoptosis in mouse neuroblastoma cells - Studies on involvement of adenosine receptors and adenosine uptake, BIOCH PHARM, 61(4), 2001, pp. 417-425
Authors:
Kourounakis, AP
Van der Klein, PAM
Ijzerman, AP
Citation: Ap. Kourounakis et al., Elucidation of structure-activity relationships of 2-amino-3-benzoylthiophenes: Study of their allosteric enhancing vs. antagonistic activity on adenosine A(1) receptors, DRUG DEV R, 49(4), 2000, pp. 227-237
Authors:
de Zwart, M
de Groote, M
van der Klein, PAM
van Dun, S
Bronsing, R
Kunzel, JKVD
Ijzerman, AP
Citation: M. De Zwart et al., Phenyl-substituted N-6-phenyladenosines and N-6-phenyl-5 '-N-ethylcarboxamidoadenosines with high activity at human adenosine A(2B) receptors, DRUG DEV R, 49(2), 2000, pp. 85-93
Authors:
Beukers, MW
Den Dulk, H
Van Tilburg, EW
Brouwer, J
Ijzerman, AP
Citation: Mw. Beukers et al., Why are A(2B) receptors low-affinity adenosine receptors? Mutation of Asn273 to Tyr increases affinity of human A2B receptor for 2-(1-hexynyl) adenosine, MOLEC PHARM, 58(6), 2000, pp. 1349-1356
Authors:
Vittori, S
Lorenzen, A
Stannek, C
Costanzi, S
Volpini, R
Ijzerman, AP
Kunzel, JKVD
Cristalli, G
Citation: S. Vittori et al., N-cycloalkyl derivatives of adenosine and 1-deazaadenosine as agonists andpartial agonists of the A(1) adenosine receptor, J MED CHEM, 43(2), 2000, pp. 250-260
Citation: Raf. Deligt et al., Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery (vol 130, pg 1, 2000), BR J PHARM, 131(1), 2000, pp. 160-160
Authors:
de Ligt, RAF
Kourounakis, AP
Ijzerman, AP
Citation: Raf. De Ligt et al., Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery, BR J PHARM, 130(1), 2000, pp. 1-12
Authors:
de Zwart, M
Vollinga, RC
Beukers, MW
Sleegers, DF
Kunzel, JKVD
de Groote, M
Ijzerman, AP
Citation: M. De Zwart et al., Potent antagonists for the human adenosine A(2B) receptor. Derivatives of the triazolotriazine adenosine receptor antagonist ZM241385 with high affinity, DRUG DEV R, 48(3), 1999, pp. 95-103
Citation: Ka. Jacobson et al., 1,3-dialkylxanthine derivatives having high potency as antagonists at human A(2B) adenosine receptors, DRUG DEV R, 47(1), 1999, pp. 45-53
Authors:
Zuurmond, HM
Hessling, J
Bluml, K
Lohse, M
Ijzerman, AP
Citation: Hm. Zuurmond et al., Study of interaction between agonists and Asn293 in helix VI of human beta(2)-adrenergic receptor, MOLEC PHARM, 56(5), 1999, pp. 909-916
Authors:
Van der Graaf, PH
Van Schaick, EA
Visser, SAG
De Greef, HJMM
Ijzerman, AP
Danhof, M
Citation: Ph. Van Der Graaf et al., Mechanism-based pharmacokinetic-pharmacodynamic modeling of antilipolytic effects of adenosine A(1) receptor agonists in rats: Prediction of tissue-dependent efficacy in vivo, J PHARM EXP, 290(2), 1999, pp. 702-709